论文部分内容阅读
目的:探讨沙丁胺醇联合沐舒坦治疗慢阻肺的用药方法,观察治疗效果,为临床实践提供参考和指导。方法:将64例慢阻肺患者作为研究对象,分设常规治疗组和治疗研究组,每组随机分配患者32例。对常规治疗组患者仅进行消炎、吸痰、解痉、吸氧等常规治疗,对治疗研究组患者在常规治疗的基础上,进一步予以沙丁胺醇与沐舒坦进行联合用药治疗。结果:治疗研究组患者的治疗总有效率显著高于常规治疗组,对比差异明显,且具有统计学意义。结论:对慢阻肺患者在常规治疗的基础上,进一步予以其沙丁胺醇与沐舒坦进行联合用药治疗,可以取得更好的治疗效果,值得加强推广与实践。
Objective: To explore the use of salbutamol combined with mucosolvan in the treatment of chronic obstructive pulmonary disease, to observe the therapeutic effect and provide reference and guidance for clinical practice. Methods: Sixty-four COPD patients were divided into routine treatment group and treatment study group, 32 patients in each group were randomized. Patients in the conventional treatment group were treated only with conventional treatments such as anti-inflammatory, suctioning, spasmolyzing and oxygen inhalation. Patients in the treatment study group were further treated with salbutamol and mucosolvan on the basis of conventional treatment. Results: The total effective rate of treatment study group was significantly higher than that of conventional treatment group, the difference was significant and statistically significant. Conclusion: It is worth to strengthen the popularization and practice on the basis of routine treatment for patients with COPD who are further treated with combination therapy of salbutamol and ambroxol to achieve better therapeutic effect.